Key Sessions
Lisa Ooi
Driving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region
A*STAR
Muthiah (Mano) Manoharan, PhD
Oligonucleotide in the Spotlight - Durable Innovation and delivery of RNAi Therapeutics
Alnylam Pharmaceuticals
Day 1 - UTC+08:00
Day 1
- UTC+08:00
7:45am - 8:50am65 mins
Registration
8:50am - 9:00am10 mins
Keynote
RNA Leaders Welcome
- Jade Osei-Tutu - Head of RNA Leaders, Informa Connect
9:00am - 9:20am20 mins
Keynote
Keynote: mRNA in the Spotlight- a Personalised Medicine, Drug Target, Biomarker, and Vaccines
- Lisa Ooi - Assistant CEO, A*STAR
9:20am - 10:05am45 mins
Keynote
Driving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region
- Lisa Ooi - Assistant CEO, A*STAR
- Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
- Phoebe Dunn - CEO, mRNA Victoria
10:05am - 10:30am25 mins
Keynote
Oligonucleotide in the Spotlight - Durable Innovation and delivery of RNAi Therapeutics
- Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
10:30am - 11:15am45 mins
Networking Break
11:15am - 11:45am30 mins
Future of RNA Medicines - Transformative Next-Gen RNA and Personalised Discovery Approaches
AI-enabled RNA-based diagnosis and therapeutics
- Sheng Zong - Director, Center for AI in Biomedicine, University of California San Diego
11:45am - 12:15pm30 mins
Future of RNA Medicines - Transformative Next-Gen RNA and Personalised Discovery Approaches
Innovating novel screening systems for the discovery and optimization of ASO and siRNA therapeutics
- Dillon Flood - Scientific Director, GSK
12:15pm - 12:45pm30 mins
Future of RNA Medicines - Transformative Next-Gen RNA and Personalised Discovery Approaches
circVec - a novel circular RNA expression system to enhance gene and cell therapies
12:45pm - 2:00pm75 mins
Lunch
2:00pm - 2:30pm30 mins
Exploring RNA Therapeutics Clinical Highlights
RNAa - The Dawn of a New Therapeutic Era
- Long-Cheng Li - CEO, Ractigen Therapeutics
2:30pm - 3:00pm30 mins
Exploring RNA Therapeutics Clinical Highlights
Using siRNA to target Cardiovascular diseases, working from Discovery to Clinical evaluation
- Zicai Liang - Chairman and CEO, Suzhou Ribo Life Science Co. Ltd.
3:00pm - 3:30pm30 mins
Exploring RNA Therapeutics Clinical Highlights
Developing Robust mRNA Pharmacology Data for Clinical Advancement
3:30pm - 4:00pm30 mins
Networking Break
4:00pm - 4:30pm30 mins
Delivery, Stability, Formulation and Distribution
Deep-Dive into novel LNP modifications and Formulation for next-generation mRNA therapeutics
- Shiro Akinaga - CEO, NANO MRNA
4:30pm - 5:00pm30 mins
Delivery, Stability, Formulation and Distribution
Bispecific antibody-mediated cell-selective mRNA-LNP delivery
- Seth Cheetham - Deputy Director, BASE mRNA facility, The University of Queensland
5:00pm - 5:30pm30 mins
Delivery, Stability, Formulation and Distribution
Unlocking the Full Potential of RNAi with LEAD Technology
- Weimin Wang, PhD - Founder & CEO, Sanegene Bio
5:30pm - 6:45pm75 mins
Poster & Drinks Reception
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。